Israel- Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute

Numinus to Participate in the KCSA Mental Health Virtual Investor Conference...

Thinking Beyond Set and Setting in the Psychedelic Experience

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule...

Wesana Health Announces Receipt of Short-Term Loan

PT378 – Course Corrections, Preparation, and High-dose Experiences: “Who Are You...

Psychedelic Bulletin #127: Psilocybin Shows Promise in Bipolar Disorder; Gilgamesh Raises...

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health...

The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort...

First Patient Dosed in Small Pharma’s Drug Interaction Study

Load more